摘要
受益与风险的平衡使得目前视神经脊髓炎的药物治疗仍存挑战,这对中医药干预是一个机遇,尽管其相关研究仍处于初始阶段。我们对近年来相关文献进行查阅,并予以综述。
It is still a challenge for treating NMO（neuromyelitis optica） due to the needs of balance between effect and risk. For Traditional Chinese Medicine, challenge means an opportunity although related studies are still in the initial. We were driven to review recent literatures aiming at clarifying clue, highlighting advantage, finding out deficiency and providing evidence for deep research.
出处
《中国中医眼科杂志》
2017年第2期125-127,共3页
China Journal of Chinese Ophthalmology
关键词
视神经脊髓炎
中医药
研究进展
neuromyelitis optica
Traditional Chinese Medicine
research progress
